Cancer stem cells: advances in knowledge and implications for cancer therapy

X Chu, W Tian, J Ning, G Xiao, Y Zhou… - … and Targeted Therapy, 2024 - nature.com
Cancer stem cells (CSCs), a small subset of cells in tumors that are characterized by self-
renewal and continuous proliferation, lead to tumorigenesis, metastasis, and maintain tumor …

[HTML][HTML] Function and regulation of the PEA3 subfamily of ETS transcription factors in cancer

T Qi, Q Qu, G Li, J Wang, H Zhu, Z Yang… - American journal of …, 2020 - ncbi.nlm.nih.gov
The PEA3 subfamily is a subgroup of the E26 transformation-specific (ETS) family. Its
members, ETV1, ETV4, and ETV5, have been found to be overexpressed in multiple …

Collagen family and other matrix remodeling proteins identified by bioinformatics analysis as hub genes involved in gastric cancer progression and prognosis

M Chivu-Economescu, LG Necula, L Matei… - International Journal of …, 2022 - mdpi.com
Gastric cancer has remained in the top five cancers for over ten years, both in terms of
incidence and mortality due to the shortage of biomarkers for disease follow-up and effective …

[HTML][HTML] miR-98-5p inhibits gastric cancer cell stemness and chemoresistance by targeting branched-chain aminotransferases 1

P Zhan, X Shu, M Chen, L Sun, L Yu, J Liu, L Sun… - Life Sciences, 2021 - Elsevier
Aims Gastric cancer stem cells (GCSCs) have been used as a therapeutic target. This study
aims to estimate the role of miR-98-5p (termed miR-98) in the development of GCSCs. Main …

Antibody drug conjugates in gastrointestinal cancer: From lab to clinical development

D Singh, D Dheer, A Samykutty, R Shankar - Journal of Controlled Release, 2021 - Elsevier
The antibody-drug conjugates (ADCs) are one the fastest growing biotherapeutics in
oncology and are still in their infancy in gastrointestinal (GI) cancer for clinical applications to …

Tumor-suppressive E3 ubiquitin ligase CHIP inhibits the PBK/ERK axis to repress stem cell properties and radioresistance in non-small cell lung cancer

B Tan, J Zhang, W Wang, H Ma, Y Yang - Apoptosis, 2023 - Springer
Recently, radioresistant cancer cells surviving radiotherapy have been suggested to show
more aggressive phenotypes than parental cells, and the underlying mechanisms may be …

[HTML][HTML] Roles of long noncoding RNAs on tumor immune escape by regulating immune cells differentiation and function

L Chang, J Li, J Ding, Y Lian, C Huangfu… - American journal of …, 2021 - ncbi.nlm.nih.gov
A long noncoding RNA (lncRNA) transcript is generally more than 200 nucleotides in length
and rarely codes for any protein. Currently, many lncRNAs have been identified among …

Targeted immunotherapy to cancer stem cells: a novel strategy of anticancer immunotherapy

SY Yi, MZ Wei, L Zhao - Critical Reviews in Oncology/Hematology, 2024 - Elsevier
Cancer is a major disease that endangers human health. Cancer drug resistance and
relapse are the two main causes contributing to cancer treatment failure. Cancer stem cells …

Current understanding of cancer stem cells: Immune evasion and targeted immunotherapy in gastrointestinal malignancies

J An, X Hu, F Liu - Frontiers in Oncology, 2023 - frontiersin.org
As a relatively rare population of cancer cells existing in the tumor microenvironment, cancer
stem cells (CSCs) possess properties of immune privilege to evade the attack of immune …

MicroRNA-98 as a novel diagnostic marker and therapeutic target in cancer patients

I Akhlaghipour, M Moghbeli - Discover Oncology, 2024 - Springer
The progress of cancer treatment methods in the last decade has significantly reduced
mortality rate among these patients. Nevertheless, cancer is still recognized as one of the …